Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Facchini

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I study of vinorelbine and paclitaxel in small-cell lung cancerR V Iaffaioli, G Facchini, A Tortoriello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Modulated dialysis: a new strategy for the treatment of intradialytic intoleranceS Stefoni, L Coli, F Zacă, et al.
European Review for Medical and Pharmacological Sciences|December 18, 2020
COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicineR Di Franco, V Borzillo, E D'Ippolito, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Carboplatin and alpha-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot studyG Frasci, A Tortoriello, G Facchini, et al.
Gynecologic Oncology|July 1, 1993
Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-alpha 2b in ovarian cancer patients with minimal residual diseaseG Frasci, A Tortoriello, G Facchini, et al.
European Review for Medical and Pharmacological Sciences|January 5, 2017
Antioxidant diet and genotyping as tools for the prevention of liver diseaseR Di Francia, L Rinaldi, M Cillo, et al.
European Journal of Gynaecological Oncology|January 1, 1991
Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary dataR V Iaffaioli, G Frasci, G Facchini, et al.
Life Support Systems : the Journal of the European Society for Artificial Organs|January 1, 1985
Arteritis with acute renal failure: response to plasmapheresis treatmentG M Frascà, A Vangelista, G L D'Arcangelo, et al.
Transplantation Proceedings|June 8, 2006
Prometheus system: a technological support in liver failureA Santoro, S Faenza, E Mancini, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 1, 2012
Multidisciplinary treatment of early stage endometrial cancerS C Cecere, C Pisano, A Bamias, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I study of vinorelbine and paclitaxel in small-cell lung cancerR V Iaffaioli, G Facchini, A Tortoriello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Modulated dialysis: a new strategy for the treatment of intradialytic intoleranceS Stefoni, L Coli, F Zacă, et al.
European Review for Medical and Pharmacological Sciences|December 18, 2020
COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicineR Di Franco, V Borzillo, E D'Ippolito, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Carboplatin and alpha-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot studyG Frasci, A Tortoriello, G Facchini, et al.
Gynecologic Oncology|July 1, 1993
Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-alpha 2b in ovarian cancer patients with minimal residual diseaseG Frasci, A Tortoriello, G Facchini, et al.
European Review for Medical and Pharmacological Sciences|January 5, 2017
Antioxidant diet and genotyping as tools for the prevention of liver diseaseR Di Francia, L Rinaldi, M Cillo, et al.
European Journal of Gynaecological Oncology|January 1, 1991
Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary dataR V Iaffaioli, G Frasci, G Facchini, et al.
Life Support Systems : the Journal of the European Society for Artificial Organs|January 1, 1985
Arteritis with acute renal failure: response to plasmapheresis treatmentG M Frascà, A Vangelista, G L D'Arcangelo, et al.
Transplantation Proceedings|June 8, 2006
Prometheus system: a technological support in liver failureA Santoro, S Faenza, E Mancini, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 1, 2012
Multidisciplinary treatment of early stage endometrial cancerS C Cecere, C Pisano, A Bamias, et al.
Pageof 9